Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Mol Med ; 47: e160, 2015 Apr 24.
Article in English | MEDLINE | ID: mdl-25907110

ABSTRACT

The axis of nuclear factor κB (NF-κB)-inducible NO synthase (iNOS)-nitric oxide plays a key role in cytokine- and streptozotocin-mediated pancreatic ß-cell damage. In this study, we investigated the effects of kazinol C and isokazinol D isolated from Broussonetia kazinoki on the ß-cell viability and function. RINm5F cells and primary islets were used for in vitro and ex vivo cytokine toxicity experiments, respectively. For type 1 diabetes induction, mice were injected with multiple low-dose streptozotocin (MLDS). Cytokine-induced toxicity was completely abolished in both RINm5F cells and islets that were pretreated with either kazinol C or isokazinol D. Both kazinols inhibited the NF-κB signaling pathway, thereby inhibiting cytokine-mediated iNOS induction, nitric oxide production, apoptotic cell death and defects in insulin secretion. Moreover, the occurrence of diabetes in MLDS-treated mice was efficiently attenuated in kazinol-pretreated mice. Immunohistochemical analysis revealed that the numbers of terminal deoxynucleotidyl transferase dUTP nick end labeling-positive apoptotic cells and nuclear p65-positive cells were significantly decreased in kazinol-pretreated mice. Our results suggest that kazinol C and isokazinol D block the NF-κB pathway, thus reducing the extent of ß-cell damage. Therefore, kazinol C and isokazinol D may have therapeutic value in delaying pancreatic ß-cell damage in type 1 diabetes.


Subject(s)
Broussonetia/chemistry , Cytokines/immunology , Diabetes Mellitus, Type 1/prevention & control , Hemiterpenes/therapeutic use , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/pathology , Resorcinols/therapeutic use , Animals , Apoptosis/drug effects , Cell Line , Cells, Cultured , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/pathology , Hemiterpenes/chemistry , Hemiterpenes/isolation & purification , Insulin-Secreting Cells/immunology , Male , Mice , Mice, Inbred C57BL , NF-kappa B/immunology , Nitric Oxide/immunology , Rats , Resorcinols/chemistry , Resorcinols/isolation & purification , Signal Transduction/drug effects
2.
Curr Drug Targets ; 14(9): 959-63, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23469875

ABSTRACT

Several natural compounds containing an anthraquinone core linked to a prenyloxy chain have been reported in the literature in recent years. The discovery in the plant kingdom of such secondary metabolites is a novel acquisition in the phytochemistry research field and in many cases led to a re-consideration of the secondary metabolite pool of well known anthraquinone-containing plants. In this review article we will focus on the phytochemistry and pharmacognosy of prenyloxyanthraquinones putting in evidence the natural sources and their biological properties as anti-microbial and anticancer agents.


Subject(s)
Anthraquinones/chemistry , Anthraquinones/pharmacology , Hemiterpenes/chemistry , Hemiterpenes/pharmacology , Monoterpenes/chemistry , Monoterpenes/pharmacology , Phytochemicals/chemistry , Phytochemicals/pharmacology , Anthraquinones/isolation & purification , Anthraquinones/therapeutic use , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Hemiterpenes/isolation & purification , Hemiterpenes/therapeutic use , Humans , Molecular Structure , Monoterpenes/therapeutic use , Pharmacognosy , Phytochemicals/therapeutic use , Phytotherapy , Plants/chemistry , Secondary Metabolism
3.
Curr Cancer Drug Targets ; 12(9): 1173-90, 2012 Nov 01.
Article in English | MEDLINE | ID: mdl-22873216

ABSTRACT

Bioactive food components (BFACs) represent promising candidates for liver cancer chemoprevention. Among them, isoprenic derivatives (carotenoids, retinoids, perillyl alcohol, limonene, geraniol, farnesol, geranylgeraniol and ß- ionone) can be highlighted. The relevance of animal models for the investigation of chemopreventive agents is supported by comparative functional genomic studies that reinforce the similarities between rodent and human hepatocarcinogenesis. Thus, characterization of BFACs in animal models as blocking and/or suppressing agents allows the establishment of the theoretical basis for the development of chemoprevention strategies. Dietary isoprenic derivatives actions on hepatocarcinogenesis may involve a block in carcinogen activation, induction of phase 2 enzymes and an antioxidant activity, as well as interference with cellular processes including cell communication, proliferation, apoptosis, differentiation and remodeling of preneoplastic lesions. Dietary isoprenic derivatives modulate molecular targets including HMG-CoA-reductase, Rho, nuclear receptors, c-myc, connexin 43, NF-κB and Nrf2. Several networks related to these targets are altered in early phases of hepatocarcinogenesis. This emphasizes the importance of such agents for the chemoprevention of hepatocellular carcinoma. Combinations of isoprenic derivatives or of these substances with other BFACs classes should be further investigated. Also, toxicity and bioavailability and pharmacokinetic aspects of these derivatives represent relevant issues in their development as chemopreventive agents. One major current limitation of the adoption of dietary isoprenic derivatives for liver cancer chemoprevention is the challenge in overcoming the initial preclinical phase in agent development. Dietary isoprenic derivatives that present liver cancer chemopreventive properties should be further explored in clinical trials, begining with the phase 0 approach.


Subject(s)
Antineoplastic Agents/therapeutic use , Butadienes/therapeutic use , Carcinoma, Hepatocellular/prevention & control , Diet , Hemiterpenes/therapeutic use , Liver Neoplasms/prevention & control , Molecular Targeted Therapy , Pentanes/therapeutic use , Animals , Butadienes/chemistry , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Hemiterpenes/chemistry , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Pentanes/chemistry
4.
Bioorg Med Chem Lett ; 19(18): 5419-22, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19679472

ABSTRACT

In this study, we synthesized some natural and semi-synthetic prenyloxyphenylpropanoids (e.g., acetophenones, benzoic and cinnamic acids, chalcones, and coumarins), and we assessed their in vivo neuroprotective activity, using the mouse maximal electroshock-induced seizure model (MES test). 7-Isopentenyloxycoumarin and (2E)-3-{4-[(3-methylbut-2-enyl)oxy]phenyl}prop-2-enoic acid, administered ip at a dose of 300 mg/kg, suppressed MES-induced seizures in mice in a time- and dose-dependent manner.


Subject(s)
Anticonvulsants/chemical synthesis , Anticonvulsants/therapeutic use , Hemiterpenes/chemical synthesis , Hemiterpenes/therapeutic use , Phenyl Ethers/chemical synthesis , Phenyl Ethers/therapeutic use , Seizures/drug therapy , Animals , Anticonvulsants/chemistry , Dose-Response Relationship, Drug , Electroshock , Hemiterpenes/chemistry , Mice , Phenyl Ethers/chemistry
5.
Phytother Res ; 17(2): 155-9, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12601679

ABSTRACT

In the present study, it was demonstrated that the hexanic extract obtained from the roots of Lonchocarpus sericeus and one of its major components, derricin, but not lonchocarpin, show cytotoxic activity to fertilized sea urchin eggs. Both inhibited the first cleavage of sea urchin eggs in a dose-dependent manner with an IC(50) of 30.4 (26.2-35.3) microgram/mL for the crude extract and 51.2 (42.1-62.3) microgram/mL for derricin (n = 6, in both cases). Furthermore, the hexanic extract of L. sericeus, and the isolated compounds, derricin and lonchocarpin showed cytotoxicity against CEM leukaemic cell line (IC(50) = 17.6 (13.7-22.6), 13.0 (12.0-14.0) and 10.4 (5.6-19.1) microgram/ml (n = 6), respectively). When these substances (6.25 to 125 microgram/25 microL) were examined for antimicrobial activity against Escherichia coli, Staphylococcus aureus and Candida albicans, none of them were found to be active. Neither the hexanic extract, nor the isolated compounds derricin and lonchocarpin (0.5 to 250 microgram/mL) presented hemolytic activity. These results indicated a possible antimitotic activity of L. sericeus crude extract and their major constituents.


Subject(s)
Anti-Infective Agents/pharmacology , Antineoplastic Agents/pharmacology , Chalcones/pharmacology , Hemiterpenes/pharmacology , Millettia , Phytotherapy , Plant Extracts/pharmacology , Animals , Anti-Bacterial Agents , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Candida albicans/drug effects , Chalcones/administration & dosage , Chalcones/therapeutic use , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Hemiterpenes/administration & dosage , Hemiterpenes/therapeutic use , Hemolysis/drug effects , Humans , Inhibitory Concentration 50 , Microbial Sensitivity Tests , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Plant Roots , Sea Urchins/drug effects , Staphylococcus aureus/drug effects , Tumor Cells, Cultured/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...